The Recall Desk
SevereFDA (Drugs)·D-0280-2017·Announced 2017-01-11

Tri-Coast Pharmacy Recalls Quad Mix Due to Sterility Concerns

Tri-Coast Pharmacy is recalling Quad Mix compounded drug products because they may not be sterile. The recall covers vials compounded between May and November 2016.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in a drug product, which poses a risk of serious injury or death from infection, meeting the criteria for a Severe rating.

Plain-English summary

Tri-Coast Pharmacy is recalling specific lots of Quad Mix, a compounded drug product containing Alprostadil, Phentolamine, Papaverine, and Atropine. The recall is being conducted because the products lack assurance of sterility.

The recall includes all sterile products compounded between May 17, 2016, and November 17, 2016. The known lot code is 05242016A, with an expiration date of July 8, 2016. The product was distributed nationwide in 5-vial packages.

Consumers and healthcare providers should stop using the affected products and contact their pharmacist or the recalling firm for instructions on return or replacement.

The recalled product

Product
Quad Mix, Alprostadil/Phentolamine/Papaverine/Atropine 40mcg/2mg/40mg/0.04mg/ml, (1 ML). Compounded by Tri-Coast Pharmacy
Manufacturer
Tri-Coast Pharmacy
Affected units
5

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →